NEOBE THERAPEUTICS
Engineering biologics to overcome immunologically cold tumours
At Neobe, they are harnessing the synthetic biology toolkit to engineer tumour-colonizing bacteria that locally disrupt this microenvironment
Annelise Soulier & Pedro Correa de Sampaio co-founded Neobe Therapeutics recently and are looking at getting into clinical trials in just a few years.